Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer ResearchGlobeNewsWire • 01/18/22
Chimerix Announces Positive ONC201 Data in Recurrent H3 K27M-mutant Diffuse Midline Glioma to Be Presented at the Society for Neuro-Oncology Annual MeetingGlobeNewsWire • 11/19/21
Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021GlobeNewsWire • 11/11/21
Chimerix, Inc. (CMRX) CEO Mike Sherman on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/06/21
Chimerix Reports Third Quarter 2021 Financial Results and Provides Operational UpdateGlobeNewsWire • 11/04/21
Analysts Estimate Chimerix (CMRX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 10/28/21
Chimerix to Report Third Quarter 2021 Financial Results and Provide an Operational Update on November 4, 2021GlobeNewsWire • 10/28/21
Chimerix to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/07/21
Chimerix, Inc. (CMRX) CEO Mike Sherman on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/21
Chimerix to Report Second Quarter 2021 Financial Results and Provide an Operational Update on August 5, 2021GlobeNewsWire • 07/29/21
Chimerix Receives U.S. Food and Drug Administration Approval for TEMBEXA® (brincidofovir) for the Treatment of SmallpoxGlobeNewsWire • 06/04/21
Chimerix Announces Upcoming Presentations at the American Society of Clinical Oncology 2021 Annual MeetingGlobeNewsWire • 05/19/21
Chimerix's (CMRX) CEO Mike Sherman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/08/21
Chimerix Reports First Quarter 2021 Financial Results and Provides Operational UpdateGlobeNewsWire • 05/06/21
Chimerix to Report First Quarter 2021 Financial Results and Provide an Operational Update on May 6, 2021GlobeNewsWire • 04/29/21
Chimerix Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2021GlobeNewsWire • 04/08/21
5 Small-Cap Biotech Stocks Trading Under $10 With Massive Upside Potential24/7 Wall Street • 04/03/21
Chimerix to Present at Virtual H.C. Wainwright Global Life Sciences ConferenceGlobeNewsWire • 03/02/21